Using Complete Blood Cell Counts to Diagnose Disease

Similar documents
Ebola Facts. October 14, 2014

Lab: Blood Smear and RBC Count

A GUIDE TO THIS REFLECTIONS B RESEARCH STUDY IF YOU RE FIGHTING BREAST CANCER, YOU RE NOT ALONE

MEDICATION GUIDE RIBAVIRIN TABLETS Rx Only Read this Medication Guide carefully before you start taking ribavirin tablets and read the Medication

Preparation thin blood films and Giemsa staining

Blood Product Utilization

Illumina Clinical Services Laboratory

Training Bulletin. Emergency Health Services Branch Ministry of Health and Long-Term Care. October 24, Issue Number version 2.

LEARN. about. Please see Important Safety Information on pages 3-5 and enclosed full Prescribing Information.

Smouldering myeloma. Myeloma Infosheet Series. Other related conditions. Infoline:

Thermal Imaging for Detecting Potential SARS Infection

Enoxaparin (Lovenox )

Treatment: Nutrition and Medication

Hypochromic/Microcytic Anemias

Diagnostic smartphone application for anemia in developing countries

Package leaflet: Information for the user. HUMAN ALBUMIN BAXALTA 200 g/l Solution for Infusion. Human albumin

Coordinated Primary Options Service. DVT Management Plan. Management options using Dabigatran or Warfarin

Surname. Number OXFORD CAMBRIDGE AND RSA EXAMINATIONS ADVANCED SUBSIDIARY GCE G623 APPLIED SCIENCE. Cells and Molecules

INTRODUCTION: TECHNICAL DESIGN:

Welcome Back to the Framingham Heart Study

Automated Hematology System. Your Complete Choice

This Infosheet explains what Monoclonal Gammopathy of Undetermined Significance (MGUS) is and how it is diagnosed and managed.

Medical History Questionnaire

SF Cube. Exclusive Technology, Inclusive Approach. BC-6800 Auto Hematology Analyzer. Cell Analysis Technology

The UAB Informatics Institute and Why It Isn't Just a Division of Computer Science. James J. Cimino, MD Director, UAB Informatics Institute

Iron Deficiency Anemia

Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Temporal Aspects.


Material Safety Data Sheet

For a full listing of nonmedicinal ingredients see Part 1 of the product monograph. PART III: CONSUMER INFORMATION

SAMPLE PROCEDURE , 11/07

CHEMILUMINESCENCE ENZYME IMMUNOASSAY (CLIA) THYROID STIMULATING HORMONE (FERRITIN) Ferritin

Review. 0 Genotype: alleles that are present 0 Phenotype: physical appearance. 0 If Red is dominant to white, what is the phenotype of the above?

SOP.9. Manually counting and spiking of cells in blood

Patient Case and Question

PERFORMANCE CRITERIA To be competent you must achieve the following:

Learn more about why severe RSV disease APPROVED USE

Safety Data Sheet European Format

GUIDELINES FOR EMPLOYEE S HEALTH - AN USEFUL TOOL FOR WORKPLACE HEALTH PROTECTION

Treatment strategies for relapsing and refractory myeloma

PLTW Biomedical Science Principles of Biomedical Science Course Outline

CONCURRENT 10: THE COMPLETE BLOOD COUNT AND BEYOND: QUALITY ISSUES AND REFERENCE METHODS

Introduction PART. 1 Why Technicians Need to Study Pharmacology and Therapeutics. 2 Pharmacokinetics

VAE Questions and Case Studies

Immunofluorescence Staining Protocol for 3 Well Chamber, removable

1 Adequate. Some key words were used and used correctly. Some errors were made in the use of key words.

University of Michigan

MSDS FOR ZINC METAL: PRIME WESTERN

FRANCHE COMMUNITY PRIMARY SCHOOL & Policies & Procedures

Material Safety Data Sheet

AAG PRINCIPLE SPECIMEN. REF (150 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

Miramont Family Medicine

MICROARRAY HYBRIDISATION PROTOCOL 10/05 (for both PCR and Oligo arrays on UltraGAPS slides)

The tale of the five blind men s first encounter. Business, Blind Men, and Elephants: The Need for an Integrated Performance Measurement System

Table of Contents 1.0 Introduction Thawing Cells, Plating and Colony Enumeration...2

The Story of the Platelet Clump. Wayne Hall MTN Network Laboratory Magee-Womens Research Institute Pittsburgh, PA

GE Healthcare. Vivid S6. Cardiovascular ultrasound system

Carbon Monoxide at the Work Site

Ebola Q & A. # Question Answer Modified

Clinical Policy: Eculizumab (Soliris) Reference Number: ERX.SPMN.225

Final Approval: October 2010 Effective: October 2010 Next Review Date: August 2012

Effects of Antibiotic Treatment on the Results of Nested ACCEPTED. Polymerase Chain Reactions for Scrub Typhus

MATERIAL SAFETY DATA SHEET (FOR DOMESTIC [USA] CUSTOMERS)

PLP 6404 Epidemiology of Plant Diseases Spring 2015 LAB 2 PHASES IN THE DISEASE CYCLE: GREENHOUSE AND LAB EXERCISE

BEYOND A BETTER BOX DI-60 INTEGRATED SLIDE PROCESSING SYSTEM. Seamless Integration

Dr Pepper Snapple Created a Movement to Address Metabolic Syndrome. Sept. 19, 2017

MATERIAL SAFETY DATA SHEET EXT NANO-CERAMIC GREASE

Salmonella paratyphi Real Time PCR Kit

2018 Media Guide HEADACHE. The Journal of Head and Face Pain

This talk will cover. Treatment for relapsed and/or refractory myeloma. What is relapsed myeloma and refractory myeloma. Treatment options for relapse

Massive Haemorrhage J Davies B Ferguson

Recent applications in the industry sector concerning cost management

Assessing quality-assured diagnoses made by TB laboratories

4_ANALYSIS OF PHYTOPLANKTON SAMPLES

The Myeloma Guide Information for Patients and Caregivers

AVONEX. What is in this Leaflet. What AVONEX is used for. Before you use AVONEX. Interferon beta-1a. Consumer Medicine Information

Upon completion of the Clinical Hematology rotation, the MLS student will be able to:

Pre-Analytic Issues in Laboratory Medicine

XN Hematology Case Studies Every Picture Tells a Story

Cranio-caudal Fixation Unit CC-GE MR10063-CC-GE

Activity 5.1.4: Gram Staining

Phytoplankton Methodology

HS Principles of the Biomedical Sciences Science

How to perform-control immunostaining experiment - microscopist subjective point of view. Pawel Pasierbek

Genetic Engineering: Way to Grow

Throwing the Dice: Teaching the Hemocytometer

Office for Human Subject Protection. University of Rochester

1. APPROVED MALARIA RDTS

The clinical utility of IPF in thrombocytopenia

Material Safety Data Sheet

Wood and Human Health

INTERNATIONAL SPECIALIST IN BLOOD BANKING WORK EXPERIENCE DOCUMENTATION FORM (Routes 2 & 3)

Discussion. Principle. Laboratory Procedure Manual EXERCISE 3. Blaney, Chapter 4 The ABO and H Blood Group Systems. Textbook: 20 points.

Myeloma treatment algorithm 1999

PeliClass human IgG subclass ELISA kit Enzyme-linked immunosorbent assay

CLIA Complexity: MODERATE

Transcription:

Physiology 2 Redwood High School Name Class Period Using Complete Blood Cell Counts to Diagnose Disease Background A healthy adult has about 4.5 to 5 million red blood cells and approximately 8,000 white blood cells in each drop of blood. Determining the number of red and white blood cells can assist a healthcare specialist in the diagnosis of disease. A decrease in the number of red blood cells may indicate a condition known as anemia. A lack of red blood cells means a lack of oxygen, which can lead to symptoms such as fatigue, headache, paleness, shortness of breath, and even fainting. The presence of anemia can help direct a physician to a specific diagnosis. A decrease or increase in the number of white blood cells can also indicate a problem. For example, a large increase in white blood cells usually indicates an infection. A complete blood cell count (CBC) is a common procedure performed to determine the number of red and white blood cells in an individual. A hemocytometer is a specialized counting chamber used for blood cell counts. Blood is diluted and added to the surface of the hemocytometer that contains a grid of known volume. The number and types of cells located within each square of the grid are counted using a microscope, and are used to estimate the total amounts in blood. In the following activity, you will use a simulated hemocytometer sample to estimate the red cell, white cell and platelet counts for your patients. Additionally, you will use a simulated blood sample to practice an RBC count using hemocytometers.

Part A. Analyzing Simulated Blood using Hemocytometer/Microscopes 1. You will work with a partner to complete RBC counts, using the hemocytometers for (2) different samples of simulated blood. You will repeat the same procedures for Sample A and Sample B. 2. You will have a hemocytometer slide, cover slips, pipette and two beakers with simulated blood labeled Sample A and Sample B. Thoroughly stir the sample and, using the available pipette, immediately withdraw a small amount of simulated blood. 3. Hold the pipette at approximately 60º angle to the slide and dispense (1) drop at the edge of the cover slip. The sample should be drawn under the cover slip by capillary action and completely cover the counting chamber. 4. You will count the RBCs from (5) grids on the hemocytometer each of the four corner grids and the central grid. The grids and the pattern for their count are indicated in the figure below. 5. When you encounter cells that are touching the grid lines, count any cells touching the top and left lines and do not count cells touching the bottom and right lines. Record your results in Data Table 1. 6. Repeat steps 4 and 5 for the second counting grid on your slide (on the opposite side of the slide). 7. Wash and dry the hemocytometer slide, clean the pipette, and get a new cover slip. 8. Repeat steps 2 to 7 for the second simulated blood sample. Table 1. Simulated RBC Counts Sample A A B C D E Average Count 1 Count 2 RBC/grid RBC/grid x 10 5 = RBC/mm 3 Sample B A B C D E Average Count 1 Count 2 RBC/grid RBC/grid x 10 5 = RBC/mm 3

Table 2. Results and Diagnosis Patient Results Diagnosis/Explanation A B Part B. Analyzing Complete Blood Counts Read each patient complaint. A blood smear sample in a hemocytometer grid has been provided, as well as information on any additional abnormal observations that may help in a diagnosis. Follow the directions to perform a red blood cell, white blood cell, and platelet count. Patient 11011 A 16 y/o female was brought into the ER after she fainted while playing in a basketball game. She has been feeling fatigued and experiencing headaches over the last few weeks. Patient 22022 A 6 y/o male has been experiencing weight loss, weakness, and fatigue. The parents have been worried that he has not been hungry and is bruising easily. Patient 33033 A 71 y/o male was brought into the ER with extreme abdominal pain that is made worse by any movement. He has been experiencing some abdominal discomfort for the past few months. Patient 44044 A 26 y/o female has been experiencing fever, headache, sweating, sleepiness, fatigue, and vomiting over the last 2 weeks.

CBC Protocols

Analysis After completing the diagnosis, answer the following questions. 1. What is a complete blood cell count? How does a hemocytometer help perform a blood cell count? 2. Research any one of the diagnosed diseases. Briefly discuss the cause, effect and treatment of the condition.